Deutsche Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.1M | Buy |
1,751,252
+336,326
| +24% | +$12.1M | 0.02% | 551 |
|
|
2025
Q1 | $44M | Sell |
1,414,926
-1,775,038
| -56% | -$55.3M | 0.02% | 647 |
|
|
2024
Q4 | $81.4M | Buy |
3,189,964
+847,704
| +36% | +$21.6M | 0.03% | 512 |
|
|
2024
Q3 | $66.3M | Buy |
2,342,260
+1,362,476
| +139% | +$38.5M | 0.03% | 530 |
|
|
2024
Q2 | $25.8M | Buy |
979,784
+410,590
| +72% | +$10.8M | 0.01% | 741 |
|
|
2024
Q1 | $17.3M | Buy |
569,194
+12,189
| +2% | +$370K | 0.01% | 850 |
|
|
2023
Q4 | $15.6M | Buy |
557,005
+61,764
| +12% | +$1.73M | 0.01% | 852 |
|
|
2023
Q3 | $13.4M | Sell |
495,241
-350,974
| -41% | -$9.53M | 0.01% | 798 |
|
|
2023
Q2 | $26M | Buy |
846,215
+313,151
| +59% | +$9.63M | 0.01% | 690 |
|
|
2023
Q1 | $19.2M | Sell |
533,064
-75,001
| -12% | -$2.7M | 0.01% | 773 |
|
|
2022
Q4 | $24M | Buy |
608,065
+119,004
| +24% | +$4.7M | 0.01% | 712 |
|
|
2022
Q3 | $19.7M | Buy |
489,061
+31,101
| +7% | +$1.25M | 0.01% | 760 |
|
|
2022
Q2 | $19.3M | Sell |
457,960
-456
| -0.1% | -$19.2K | 0.01% | 791 |
|
|
2022
Q1 | $17.9M | Buy |
458,416
+27,320
| +6% | +$1.06M | 0.01% | 870 |
|
|
2021
Q4 | $17.2M | Buy |
431,096
+115,190
| +36% | +$4.59M | 0.01% | 901 |
|
|
2021
Q3 | $11.4M | Buy |
315,906
+71,998
| +30% | +$2.6M | 0.01% | 1096 |
|
|
2021
Q2 | $10M | Buy |
243,908
+68,124
| +39% | +$2.79M | ﹤0.01% | 1186 |
|
|
2021
Q1 | $7.67M | Sell |
175,784
-41,943
| -19% | -$1.83M | ﹤0.01% | 1320 |
|
|
2020
Q4 | $10.9M | Buy |
217,727
+215,925
| +11,983% | +$10.8M | 0.01% | 995 |
|
|
2020
Q3 | $76K | Buy |
+1,802
| New | +$76K | ﹤0.01% | 3612 |
|